SG Americas Securities LLC Acquires 409,831 Shares of Bath & Body Works, Inc. $BBWI

SG Americas Securities LLC boosted its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 725.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 466,338 shares of the company’s stock after purchasing an additional 409,831 shares during the quarter. SG Americas Securities LLC owned 0.23% of Bath & Body Works worth $9,364,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Assenagon Asset Management S.A. raised its position in shares of Bath & Body Works by 187.5% in the fourth quarter. Assenagon Asset Management S.A. now owns 74,644 shares of the company’s stock valued at $1,499,000 after buying an additional 48,682 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its position in Bath & Body Works by 200.4% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 137,310 shares of the company’s stock worth $3,057,000 after buying an additional 91,606 shares in the last quarter. NorthCrest Asset Manangement LLC grew its position in Bath & Body Works by 95.6% during the fourth quarter. NorthCrest Asset Manangement LLC now owns 16,880 shares of the company’s stock worth $341,000 after buying an additional 8,251 shares in the last quarter. Allworth Financial LP increased its stake in Bath & Body Works by 11.8% during the 3rd quarter. Allworth Financial LP now owns 9,719 shares of the company’s stock worth $250,000 after acquiring an additional 1,024 shares during the period. Finally, IFP Advisors Inc increased its stake in Bath & Body Works by 594.6% during the 3rd quarter. IFP Advisors Inc now owns 34,547 shares of the company’s stock worth $890,000 after acquiring an additional 29,573 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Up 0.1%

Shares of BBWI stock opened at $16.81 on Monday. The business has a fifty day simple moving average of $21.65 and a 200 day simple moving average of $22.31. The company has a market cap of $3.38 billion, a P/E ratio of 5.34, a P/E/G ratio of 1.68 and a beta of 1.48. Bath & Body Works, Inc. has a twelve month low of $14.27 and a twelve month high of $34.66.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.77 by $0.28. The firm had revenue of $2.72 billion for the quarter, compared to analysts’ expectations of $2.59 billion. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The business’s revenue for the quarter was down 2.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.09 earnings per share. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, equities research analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 6th. Investors of record on Friday, February 20th were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date was Friday, February 20th. Bath & Body Works’s dividend payout ratio is currently 25.40%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on BBWI. Zacks Research upgraded Bath & Body Works from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 20th. Weiss Ratings restated a “hold (c-)” rating on shares of Bath & Body Works in a research report on Wednesday, January 21st. Deutsche Bank Aktiengesellschaft boosted their price target on Bath & Body Works from $21.00 to $22.00 and gave the company a “hold” rating in a research note on Tuesday, March 3rd. Robert W. Baird set a $20.00 price objective on shares of Bath & Body Works in a research note on Wednesday, December 17th. Finally, Citigroup lowered shares of Bath & Body Works from a “buy” rating to a “neutral” rating and raised their target price for the company from $21.00 to $25.00 in a report on Tuesday, February 17th. Three equities research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Bath & Body Works presently has a consensus rating of “Hold” and an average target price of $24.00.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.